Veteran Bollywood director Vikram Bhatt has been named in a fraud case involving ₹30 crore, after a complaint was filed by Dr Ajay Murdia, the founder of Indira IVF. The case was registered at the Bhupalpura police station in Rajasthan, and it has attracted significant attention in the film industry.
According to the complaint, Dr Murdia was persuaded to invest in a biopic about his late wife. He alleges that Bhatt and his associates promised returns of up to ₹200 crore but misused more than ₹30 crore of his money. The FIR names Bhatt, his wife Shwetambari Bhatt, and six other individuals in connection with the alleged fraud.
In response, Vikram Bhatt has strongly denied the allegations. He described the complaint as “absolutely wrong” and “misleading.” Bhatt further claimed that forged documents may have been used to support the complaint. He also alleged that Dr Murdia had halted another film project, titled Virat, before it could be completed, leaving technicians unpaid. Bhatt stated that nearly ₹250 crore is owed to workers and insisted that he has full evidence to support his version of events.
Law enforcement authorities are currently investigating the matter. Reports suggest that Bhatt’s production house allegedly failed to deliver on a contract to produce four films, which forms part of the dispute. Police are examining financial records and documents provided by both parties to determine the truth.
The case has sparked discussions about transparency and accountability in film investments. Many in the industry are watching closely, as the allegations involve substantial sums of money and high-profile figures. Bhatt has expressed his willingness to cooperate fully with the investigation and provide all necessary documents to prove his innocence.
The legal proceedings are expected to continue for several months. The controversy highlights the risks involved in film financing and the importance of clear contracts and proper documentation. As the investigation unfolds, both parties have maintained their positions, and the outcome remains uncertain.